Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 5/20 | 0.43 |
| ▸ | DPP4 | P27487 | 6/20 | 0.40 |
| ▸ | PREP | P48147 | 1/20 | 0.39 |
| ▸ | FAP | Q12884 | 1/20 | 0.39 |
| ▸ | REN | P00797 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29727257 | 0.91 | ACE (0.41) | ACEDPP4PREPFAPREN | |
| SCHEMBL31593372 | 0.88 | MEN1 (0.39) | ACEDPP4 | |
| SCHEMBL10396256 | 0.86 | MEN1 (0.49) | ACEDPP4FAP | |
| SCHEMBL29689560 | 0.85 | ACE (0.47) | ACEDPP4PREPFAPREN | |
| SCHEMBL2122685 | 0.84 | ACE (0.48) | ACEDPP4FAPREN | |
| SCHEMBL2113641 | 0.84 | ACE (0.48) | ACEDPP4FAPREN | |
| SCHEMBL30379247 | 0.84 | PLK1 (0.41) | ACE | |
| SCHEMBL29590258 | 0.83 | NAA50 (0.41) | ACEDPP4PREPFAPREN | |
| SCHEMBL29947689 | 0.82 | ACE (0.46) | ACEDPP4PREPFAPREN | |
| SCHEMBL31165891 | 0.82 | NRP1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116568335-A | Folate receptor targeted nanoparticle drug conjugate and application thereof | 易达制药公司 | 2023-08-08 | — | — | CN | disclosed |
| EP-4103236-A1 | FOLATE RECEPTOR TARGETED NANOPARTICLE DRUG CONJUGATES AND USES THEREOF | Elucida Oncology, Inc. (US) | 2022-12-21 | — | — | EP | disclosed |
| WO-2022093793-A1 | FOLATE RECEPTOR TARGETED NANOPARTICLE DRUG CONJUGATES AND USES THEREOF | ELUCIDA ONCOLOGY, INC. (US) | 2022-05-05 | — | — | WO | disclosed |